Pedro V. Reyes-Jiménez

Mr. Pedro V. Reyes-Jiménez

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PRPedro V. Reyes-Jiménez
Pedro V. Reyes-Jiménez
BTBenilde Garcia de Teresa
Benilde Garcia de Teresa
UJUlises E Juárez-Figueroa
Ulises E Juárez-Figueroa
Fernando Perez VillatoroFernando Perez Villatoro
Fernando Perez Villatoro
Moisés Óscar Fiesco-RoaMoisés Óscar Fiesco-Roa
Moisés Óscar Fiesco-Roa
Sara FriasSara Frias
Sara Frias
Fanconi anemia (FA) is a rare genetic disorder caused by pathogenic variants (PV) in at least 22 genes, which cooperate in the Fanconi anemia/Breast Cancer (FA/BRCA) pathway to maintain genome stability. PV in FANCA, FANCC, and FANCG account for most cases (~90%). This study evaluated the chromosomal, molecular, and physical phenotypic findings of a novel founder FANCG PV, identified in three patients with FA from the Mixe community of Oaxaca, Mexico. All patients presented chromosomal instability and a homozygous PV, FANCG: c.511-3_511-2delCA, identified by next-generation sequencing analysis. Bioinformatic predictions suggest that this deletion disrupts a splice acceptor site promoting the exon 5 skipping. Analysis of Cytoscan 750 K arrays for haplotyping and global ancestry supported the Mexican origin and founder effect of the variant, reaffirming the high frequency of founder PV in FANCG. The degree of bone marrow failure and physical findings (described through the acronyms VACTERL-H and PHENOS) were used to depict the phenotype of the patients. Despite having a similar frequency of chromosomal aberrations and genetic constitution, the phenotype showed a wide spectrum of severity. The identification of a founder PV could help for a systematic and accurate genetic screening of patients with FA suspicion in this population.

17 September 2010 in Echocardiography
Verified
Journal Article
Closed access
PDF file
NZNilda Espinola Zavaleta
Nilda Espinola Zavaleta
FIFahad Mujtaba Iqbal
Fahad Mujtaba Iqbal
NNNavin C Nanda
Navin C Nanda
EEEduardo Enríquez‐Rodríguez
Eduardo Enríquez‐Rodríguez
LALuis M Amezcua-Guerra
Luis M Amezcua-Guerra
MSMaría Elena Soto
María Elena Soto

25 July 2024 in Acta Pediátrica de México
Verified
Journal Article
Open access
PDF file
SSSilvia Sánchez
Silvia Sánchez
PRPedro V. Reyes-Jiménez
Pedro V. Reyes-Jiménez
MBMarco Antonio Mejía Barrera
Marco Antonio Mejía Barrera
AMAntonio De Jesús Paz Martínez
Antonio De Jesús Paz Martínez
Sara FriasSara Frias
Sara Frias
La anemia de Fanconi es el síndrome de falla medular hereditaria más frecuente; en estos pacientes suele desarrollarse de manera progresiva y las complicaciones hematológicas pueden agravarse durante la adolescencia y la adultez temprana hasta el desarrollo de condiciones asociadas a neoplasias, como el síndrome mielodisplásico y la leucemia mieloide aguda. El inicio y evolución hacia la neoplasia en la anemia de Fanconi, ha sido asociado a pérdidas y ganancias de regiones cromosómicas y pueden ser monitoreadas a través de la búsqueda de alteraciones citogenéticas clonales, distintivas de la enfermedad que se localizan en los cromosomas 1, 3 y 7. En este artículo presentamos la metodología seguida por nuestro laboratorio para la detección y seguimiento de los cambios cromosómicos, a través de técnicas de bandeo GTG e hibridación in situ con fluorescencia. Dicha estrategia representa una forma costo-efectiva para realizar el seguimiento longitudinal de los cambios en la médula ósea de los pacientes que, de manera conjunta con el análisis morfológico y el monitoreo de los recuentos sanguíneos periféricos, permite la toma de decisiones terapéuticas oportunas, como la programación de trasplante de células troncales y progenitoras hematopoyéticas, cuando es posible.

28 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SSSILVIA SANCHEZ
SILVIA SANCHEZ
BTBenilde Garcia de Teresa
Benilde Garcia de Teresa
MMMarco A. Mejía-Barrera
Marco A. Mejía-Barrera
PRPedro V. Reyes-Jiménez
Pedro V. Reyes-Jiménez
AMAntonio De Jesús Paz Martínez
Antonio De Jesús Paz Martínez
Sara FriasSara Frias
Sara Frias
Background/objectives: Fanconi anemia (FA) is an inherited bone marrow failure syndrome characterized by chromosome instability and predisposition to develop myelodysplastic neoplasm (MDS) and acute myeloid leukemia (AML). Clonal chromosome aberrations (CCAs) in chromosomes 1, 3, and 7 frequently appear in the bone marrow (BM) of patients with FA and are associated with MDS/AML progression. Given the underlying DNA repair defect that characterizes FA, non-clonal chromosomal abnormalities (NCCAs) are expected to be common events in the FA BM; in this study, we investigated the presence and significance of NCCA and CCA in the bone marrow (BM) of patients with FA. Methods: Here, we transversally examined the BM karyotypes of 43 non-transplanted patients with FA, 41 with non-clinically detectable hematologic neoplasia and two with diagnosed MDS. We searched for the presence of NCCAs, complex karyotypes (CKs), and CCAs as well as their association with the natural history of the disease, including age, degree of BM failure, and neoplastic transformation. Results: NCCAs were observed in the metaphase spreads of 41/43 FA patients; CKs were observed in 25/43 patients; CCAs were found in 15/43 patients; CCAs involving chromosomes 1, 3 and/or 7 were found in four patients; and other autosomes were found in the remaining 11 patients. Overall, we observed a baseline large karyotypic heterogeneity in the BM of FA patients, demonstrated by the ubiquitous presence of NCCA; such karyotypic heterogeneity precedes the eventual emergence of CKs and selection of cells carrying fitness-improving CCAs. Finally, CCAs involving chromosomes 1, 3 and 7, well-known drivers of hematological malignancy in FA, become established. Overall, we observed that the frequency of NCCAs and CCAs increased with age, even though a significant correlation was not found. Conclusions: These observations fit the model of evolution towards cancer that comprises a first phase of macroevolution represented by NCCAs and karyotypic heterogeneity, followed by the establishment of clones with CCAs, leading to microevolution and cancer. NCCAs are the most frequent chromosomal alterations in the bone marrow of patients with AF and constitute a genome with extensive karyotypic heterogeneity that evolves into clones with more complex genomes and can eventually progress to cancer.

17 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SSSILVIA SANCHEZ
SILVIA SANCHEZ
BTBenilde Garcia de Teresa
Benilde Garcia de Teresa
MMMarco A. Mejía-Barrera
Marco A. Mejía-Barrera
PRPedro V. Reyes-Jiménez
Pedro V. Reyes-Jiménez
AMAntonio De Jesús Paz Martínez
Antonio De Jesús Paz Martínez
Sara FriasSara Frias
Sara Frias
Fanconi anemia (FA) is an inherited bone marrow failure syndrome characterized by chromosome instability and predisposition to develop myelodysplastic neoplasm (MDS) and acute myeloid leukemia (AML). Clonal chromosome aberrations (CCA) in chro-mosomes 1, 3, and 7 frequently appear in the bone marrow (BM) of patients with FA and associate to MDS/AML progression. Given the underlying DNA repair defect that characterizes FA, non-clonal chromosomal abnormalities (NCCA) are expected to be common events in the FA BM, however little is known about its presence and significance. Here, we transversally examined the BM karyotypes of 43 non-transplanted patients with FA, 41 with non-clinically detectable hematologic neoplasia and two with diagnosed MDS. We searched for the presence of NCCAs, complex karyotypes (CKs) and CCA, and their association with the natural history of the disease, including age, degree of BM failure, and neoplastic transformation. NCCAs were observed in the metaphase spreads of 41/43 FA patients; CKs were observed in 25/43 patients, whereas CCAs were found in 15/43 patients, CCA involving chromosomes 1, 3 and/or 7 in four patients, and other autosomes in the remaining 11 patients. Overall, we observed a baseline large karyotypic heterogeneity in the BM of FA patients, demonstrated by the ubiquitous presence of NCCA; such karyotypic heterogeneity preceding the eventual emergence of CKs and selection of cells carrying fitness-improving CCAs. Finally, CCAs involving chromosomes 1, 3 and 7, well-known drivers of hematological malignancy in FA, become established. Overall, we observed that the frequency of NCCA and CCA increased with age, even though a significant correlation was not found. Preleukemic BM of patients with FA displays a baseline large karyotypic heterogeneity, evidenced by the ubiquitous presence of NCCA; such karyotypic heterogeneity preceding the eventual emergence of CKs and selection of cells carrying fitness-improving CCAs. Finally, CCAs involving chromosomes 1, 3 and 7, well-known drivers of hematological malignancy in FA, become established. These observations fit the model of evolution towards cancer that comprises a first phase of macroevolution represented by NCCA and karyotypic heterogeneity, followed by the establishment of clones with CCA, leading to microevolution and cancer.

29 December 2021 in Preprints.org
Verified
Preprint
Open access
PDF file
PRPedro V. Reyes-Jiménez
Pedro V. Reyes-Jiménez
BTBenilde Garcia de Teresa
Benilde Garcia de Teresa
UJUlises E Juárez-Figueroa
Ulises E Juárez-Figueroa
Fernando Perez VillatoroFernando Perez Villatoro
Fernando Perez Villatoro
Moisés Óscar Fiesco-RoaMoisés Óscar Fiesco-Roa
Moisés Óscar Fiesco-Roa
Sara FriasSara Frias
Sara Frias
Fanconi anemia (FA) is a rare genetic disorder caused by pathogenic variants (PV) in at least 22 genes, which cooperate in the FA/BRCA pathway to maintain genome stability. PV in FANCA, FANCC, and FANCG account for most cases (~90%). This study evaluated the chromosomal, molecular, and phenotypic findings of a novel founder FANCG PV, identified in three patients with FA from the Mixe community of Oaxaca, Mexico. All patients presented chromosomal instability and a homozygous PV, FANCG: c.511-3_511-2delCA, identified by next-generation sequencing analysis. Bioinformatics predictions suggest that this deletion disrupts a splice acceptor site promoting the exon 5 skipping. Analysis of Cytoscan 750K arrays for haplotyping and global ancestry supported the Mexican origin and founder effect of the variant, reaffirming the high frequency of founder PV in FANCG. The degree of bone marrow failure and physical findings (described through the acronyms VACTERL-H and PHENOS) were used to depict the phenotype of the patients. Despite having a similar frequency of chromosomal aberrations and genetic constitution, the phenotype showed a wide spectrum of severity. The identification of a founder PV could help for a systematic and accurate genetic screening of patients with FA suspicion in this population.